ITEMS IN AFP WITH KEYWORD:
Apr 15, 2012 Issue
NICE Updates Guidelines on Management of Chronic Heart Failure [Practice Guidelines]
Heart failure is associated with poor prognosis and quality of life, as well as high health care costs. In 2010, the National Institute for Health and Clinical Excellence (NICE) updated its previous guideline on the management of chronic heart failure in adults. This update focuses on the role of si...
Jun 1, 2011 Issue
Brain Natriuretic Peptide for Ruling Out Heart Failure [FPIN's Clinical Inquiries]
A BNP level less than 100 pg per mL (100 ng per L) can rule out heart failure.
Mar 1, 2010 Issue
ACC and AHA Update on Chronic Heart Failure Guidelines [Practice Guidelines]
In 2009, the American College of Cardiology (ACC) and the American Heart Association (AHA) published a focused update of the ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult.
Cardiomyopathy is an anatomic and pathologic diagnosis associated with muscle or electrical dysfunction of the heart. Cardiomyopathies represent a heterogeneous group of diseases that often lead to progressive heart failure with significant morbidity and mortality. Cardiomyopathies may be primary (i...
Heart failure caused by systolic dysfunction affects more than 5 million adults in the United States and is a common source of outpatient visits to primary care physicians. Mortality rates are high, yet a number of pharmacologic interventions may improve outcomes. Other interventions, including pati...
Accurate risk stratification in patients with heart failure can help physicians choose the most appropriate place for hospitalization (general hospital ward or intensive care unit) and the intensity of care needed.
Mar 1, 2007 Issue
Diagnosis and Management of Chronic Heart Failure in Adults [Practice Guidelines]
Changes in the diagnosis and management of chronic heart failure in adults are reflected in updated guidelines from the American College of Cardiology (ACC) and American Heart Association (AHA).
Feb 1, 2007 Issue
AHRQ Evaluates Peptides as Determinants for Patients with Heart Failure [Practice Guidelines]
B-type natriuretic peptide (BNP) and N-terminal pro-hormone brain natriuretic peptide (NT-proBNP) are markers for heart failure diagnosis, prognosis, and treatment. The Agency for Healthcare Research and Quality (AHRQ) systematically reviewed available literature to further study these peptides.
Brain natriuretic peptide (BNP) levels are simple and objective measures of cardiac function. These measurements can be used to diagnose heart failure, including diastolic dysfunction, and using them has been shown to save money in the emergency department setting. The high negative predictive value...
Digoxin therapy has long been used to treat heart failure; however, its effectiveness was not completely known until recently. Results of the Digitalis Investigation Group trial showed that adding digoxin to standard heart failure therapy had no effect on mortality. However, adding digoxin decreased...